Document is current
Any future updates will be listed below
-
Authors
Datta, Alexandre N.
-
Funding
Funding for this research was provided by:
University of Basel
- License Information
-
More Information
Article History
Accepted: 22 October 2025
First Online: 25 November 2025
Declarations
:
: A.N. Datta declares the following: Consulting activities for Idorsia, Neurocrine, Epilog, Takeda, Biocodex and advisory board activities for Idorsia, Eisai, Jazz Pharmaceuticals, UCB, Angelini, Neuraxpharm. No conflict of interest.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.
: The supplement containing this article is not sponsored by industry.
